ZA200804305B - Pharmaceutical compositions comprising buprenorphine - Google Patents

Pharmaceutical compositions comprising buprenorphine

Info

Publication number: ZA200804305B
Authority: ZA; South Africa
Prior art keywords: buprenorphine; pharmaceutical compositions; pharmaceutical; compositions
Prior art date: 2005-11-21

Application number

ZA200804305A

Other languages

English (en)

Inventor

Robert D Simmons

Allan J Weingarten

Li Yuping

Original Assignee

Schering Plough Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-11-21

Filing date

2008-05-19

Publication date

2009-04-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37745944&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200804305(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-05-19 Application filed by Schering Plough Ltd filed Critical Schering Plough Ltd

2009-04-29 Publication of ZA200804305B publication Critical patent/ZA200804305B/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oil, Petroleum & Natural Gas (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Pain & Pain Management (AREA)
Emergency Medicine (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Rheumatology (AREA)
Zoology (AREA)
Dermatology (AREA)
Ophthalmology & Optometry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

ZA200804305A 2005-11-21 2008-05-19 Pharmaceutical compositions comprising buprenorphine ZA200804305B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US73852405P	2005-11-21	2005-11-21

Publications (1)

Publication Number	Publication Date
ZA200804305B true ZA200804305B (en)	2009-04-29

Family

ID=37745944

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
ZA200804305A ZA200804305B (en)	2005-11-21	2008-05-19	Pharmaceutical compositions comprising buprenorphine
ZA200804355A ZA200804355B (en)	2005-11-21	2008-05-20	Pharmaceutical compositions comprising buprenorphine

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
ZA200804355A ZA200804355B (en)	2005-11-21	2008-05-20	Pharmaceutical compositions comprising buprenorphine

Country Status (17)

Country	Link
US (2)	US20070117828A1 (fr)
EP (2)	EP1954275A2 (fr)
JP (2)	JP2009516686A (fr)
KR (1)	KR20080071185A (fr)
CN (1)	CN101312730A (fr)
AR (1)	AR058193A1 (fr)
AU (1)	AU2006316607A1 (fr)
BR (1)	BRPI0618891A2 (fr)
CA (2)	CA2629560A1 (fr)
EC (1)	ECSP088461A (fr)
NO (1)	NO20082833L (fr)
NZ (1)	NZ568313A (fr)
PE (1)	PE20070643A1 (fr)
RU (1)	RU2008124805A (fr)
TW (1)	TW200738240A (fr)
WO (2)	WO2007061828A2 (fr)
ZA (2)	ZA200804305B (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BRPI0709409A2 (pt) *	2006-03-28	2011-07-12	Javelin Pharmaceuticals Inc	composição farmacêutica e método para tratar um mamìfero necessitando de analgesia
EP2003970A4 (fr) *	2006-03-28	2012-07-11	Javelin Pharmaceuticals Inc	Formulations de médicaments anti-inflammatoires non stéroïdiens à faible dose et bêta-cyclodextrine
GB2461681A (en) *	2008-04-17	2010-01-13	Pharmasol Ltd	Buprenorphine liquid spray formulation with solvent and antioxidant
PE20081406A1 (es) *	2006-12-20	2008-10-17	Schering Plough Ltd	Composiciones farmaceuticas de flunixina
CN101842080A (zh) *	2007-11-01	2010-09-22	博士伦公司	非水的水混溶性物质作为药物递送的载体
US20110105480A1 (en) *	2008-06-24	2011-05-05	Keith Freehauf	Pharmaceutical transdermal compositions and method for treating inflammation in cattle
WO2010072398A2 (fr) *	2008-12-22	2010-07-01	Boehringer Ingelheim Limited	Formulations vétérinaires
US20120277199A1 (en) *	2009-10-21	2012-11-01	Otonomy, Inc.	Modulation of Gel Temperature of Poloxamer-Containing Formulations
US9272044B2 (en)	2010-06-08	2016-03-01	Indivior Uk Limited	Injectable flowable composition buprenorphine
GB2513060B (en)	2010-06-08	2015-01-07	Rb Pharmaceuticals Ltd	Microparticle buprenorphine suspension
CA2808628A1 (fr) *	2010-08-17	2012-02-23	Ohr Pharmaceutical, Inc.	Formulations ophtalmologiques de squalamine
US9168251B2 (en) *	2010-09-03	2015-10-27	Zoetis Belgium S.A	High dose buprenorphine compositions and use as analgesic
NO2632468T3 (fr) *	2010-10-25	2018-05-12
WO2013070656A1 (fr) *	2011-11-07	2013-05-16	Navinta Llc	Préparation de suspension à libération prolongée pour dextrométhorphane
US9962391B2 (en)	2011-12-27	2018-05-08	Cmpd Licensing, Llc	Composition and method for compounded therapy
US9468599B2 (en)	2011-12-27	2016-10-18	Cmpd Licensing, Llc	Composition and method for compounded therapy
US11213500B2 (en)	2011-12-27	2022-01-04	Cmpd Licensing, Llc	Composition and method for compounded therapy
US10813897B2 (en)	2011-12-27	2020-10-27	Cmpd Licensing, Llc	Composition and method for compounded therapy
US11213501B2 (en)	2011-12-27	2022-01-04	Cmpd Licensing, Llc	Composition and method for compounded therapy
WO2014160702A1 (fr) *	2013-03-25	2014-10-02	Chs Pharma, Inc.	Traitement de rétinopathie
EP2983668A4 (fr) *	2013-04-08	2017-01-11	Virginia Commonwealth University	Compositions pour freiner le métabolisme présystémique d'opioïdes
GB201404139D0 (en) *	2014-03-10	2014-04-23	Rb Pharmaceuticals Ltd	Sustained release buprenorphine solution formulations
CA2965895C (fr)	2014-11-07	2019-08-06	Indivior Uk Limited	L'utilisation de formules de buprenorphine a liberation continue destinees au traitement de douleur ou de troubles lies a la consommationd'opioide
EP3368013B1 (fr) *	2015-10-27	2023-11-08	Benuvia Therapeutics, LLC	Formulations liquides de buprénorphine
LT3512518T (lt) *	2016-09-13	2023-02-10	Alar Pharmaceuticals Inc.	Sulėtinto atpalaidavimo buprenorfino vaisto formos
US10646484B2 (en)	2017-06-16	2020-05-12	Indivior Uk Limited	Methods to treat opioid use disorder
GB201716830D0 (en)	2017-10-13	2017-11-29	Cambrex Charles City Inc	New Process
CA3077627A1 (fr) *	2017-10-20	2019-04-25	Chiesi Farmaceutici S.P.A.	Formulations pharmaceutiques comprenant un agoniste de recepteur d'opioide en tant que substances actives, leurs procedes de fabrication et leurs utilisations therapeutiques
CA3089114A1 (fr) *	2018-01-22	2019-07-25	Foresee Pharmaceuticals Co., Ltd.	Composition pharmaceutique pour administration a liberation prolongee de buprenorphine
FR3096890B1 (fr) *	2019-06-07	2021-05-14	H4 Orphan Pharma	Utilisation d’une molécule opioïde pour traiter l’œil sec et l’œil allergique.
US20250025457A1 (en) *	2021-09-30	2025-01-23	Elanco Us Inc.	Stable formulations of buprenorphine

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU8533582A (en) *	1981-07-10	1984-01-12	Reckitt & Colman Products Limited	Stable solutions of buprenorphine
US4626539A (en) *	1984-08-10	1986-12-02	E. I. Dupont De Nemours And Company	Trandermal delivery of opioids
IE58110B1 (en) *	1984-10-30	1993-07-14	Elan Corp Plc	Controlled release powder and process for its preparation
US4931279A (en) *	1985-08-16	1990-06-05	Bausch & Lomb Incorporated	Sustained release formulation containing an ion-exchange resin
CA2002299A1 (fr) *	1988-11-10	1990-05-10	Eugene G. Drust	Composes pour l'administration transdermique de sels de buprenorphine
US5069909A (en) *	1990-06-20	1991-12-03	Cygnus Therapeutic Systems	Transdermal administration of buprenorphine
US6384043B1 (en) *	1993-02-01	2002-05-07	Gholam A. Peyman	Methods of alleviating pain sensations of the denuded eye with opioid analgesics
US5613958A (en) *	1993-05-12	1997-03-25	Pp Holdings Inc.	Transdermal delivery systems for the modulated administration of drugs
US5871723A (en) *	1995-06-06	1999-02-16	The Regent Of The University Of Michigan	CXC chemokines as regulators of angiogenesis
AUPN814496A0 (en) *	1996-02-19	1996-03-14	Monash University	Dermal penetration enhancer
AU728120B2 (en) *	1996-03-25	2001-01-04	Lts Lohmann Therapie-Systeme Gmbh	A Transdermal therapeutic system with small application thickness and high flexibility, as well as processes for its production
US6004969A (en) *	1996-04-15	1999-12-21	National Science Council	Transdermal delivery of buprenorphine preparations
US5900420A (en) *	1997-06-19	1999-05-04	Cole; William L.	Method for treating chronic fatigue syndrome and fibromyalgia with buprenorphine
IT1302682B1 (it) *	1998-10-16	2000-09-29	Formenti Farmaceutici Spa	Composizioni farmaceutiche orali contenenti buprenorfina
KR100383252B1 (ko) *	1998-12-17	2003-07-16	주식회사 삼양사	부프레놀핀을함유하는경피투여조성물및이를포함하는패취
WO2000072835A2 (fr) *	1999-05-27	2000-12-07	El Khoury George F	Application topique d'agents muscariniques et opioides conçus pour traiter les bourdonnements d'oreilles
US6582724B2 (en) *	1999-12-16	2003-06-24	Dermatrends, Inc.	Dual enhancer composition for topical and transdermal drug delivery
KR100452972B1 (ko) *	2000-05-16	2004-10-14	주식회사 삼양사	경피투여용 하이드로젤 조성물
CA2386794A1 (fr) *	2000-07-13	2002-01-24	Euro-Celtique, S.A.	Sels et bases de 17-(cyclopropylmethyl)-4,5 alpha-epoxy-6-methylenemorphinan-3,14 diol permettant d'optimiser l'homeostasie de la dopamine pendant l'administration d'analgesiques opioides
US20040258740A1 (en) *	2003-04-10	2004-12-23	Nene Labs	Transdermal delivery composition

2006
- 2006-11-16 AR ARP060105041A patent/AR058193A1/es not_active Application Discontinuation
- 2006-11-16 NZ NZ568313A patent/NZ568313A/en not_active IP Right Cessation
- 2006-11-16 CA CA002629560A patent/CA2629560A1/fr not_active Abandoned
- 2006-11-16 BR BRPI0618891-5A patent/BRPI0618891A2/pt not_active IP Right Cessation
- 2006-11-16 US US11/600,560 patent/US20070117828A1/en not_active Abandoned
- 2006-11-16 WO PCT/US2006/044640 patent/WO2007061828A2/fr not_active Ceased
- 2006-11-16 RU RU2008124805/15A patent/RU2008124805A/ru not_active Application Discontinuation
- 2006-11-16 KR KR1020087014861A patent/KR20080071185A/ko not_active Withdrawn
- 2006-11-16 CA CA002630072A patent/CA2630072A1/fr not_active Abandoned
- 2006-11-16 CN CNA2006800434521A patent/CN101312730A/zh active Pending
- 2006-11-16 WO PCT/US2006/044464 patent/WO2007061739A2/fr not_active Ceased
- 2006-11-16 US US11/600,418 patent/US20070116730A1/en not_active Abandoned
- 2006-11-16 JP JP2008541335A patent/JP2009516686A/ja not_active Withdrawn
- 2006-11-16 EP EP06844380A patent/EP1954275A2/fr not_active Withdrawn
- 2006-11-16 PE PE2006001462A patent/PE20070643A1/es not_active Application Discontinuation
- 2006-11-16 EP EP06837885A patent/EP1951240A2/fr not_active Withdrawn
- 2006-11-16 AU AU2006316607A patent/AU2006316607A1/en not_active Abandoned
- 2006-11-16 JP JP2008541364A patent/JP2009516687A/ja active Pending
- 2006-11-17 TW TW095142635A patent/TW200738240A/zh unknown
2008
- 2008-05-19 EC EC2008008461A patent/ECSP088461A/es unknown
- 2008-05-19 ZA ZA200804305A patent/ZA200804305B/xx unknown
- 2008-05-20 ZA ZA200804355A patent/ZA200804355B/xx unknown
- 2008-06-20 NO NO20082833A patent/NO20082833L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO2007061828A3 (fr)	2007-07-19
RU2008124805A (ru)	2009-12-27
WO2007061739A2 (fr)	2007-05-31
WO2007061739A3 (fr)	2007-07-12
NO20082833L (no)	2008-07-29
WO2007061828A2 (fr)	2007-05-31
PE20070643A1 (es)	2007-08-10
BRPI0618891A2 (pt)	2011-09-13
EP1954275A2 (fr)	2008-08-13
TW200738240A (en)	2007-10-16
CA2629560A1 (fr)	2007-05-31
CN101312730A (zh)	2008-11-26
ECSP088461A (es)	2008-06-30
JP2009516687A (ja)	2009-04-23
AR058193A1 (es)	2008-01-23
JP2009516686A (ja)	2009-04-23
KR20080071185A (ko)	2008-08-01
US20070117828A1 (en)	2007-05-24
ZA200804355B (en)	2009-04-29
CA2630072A1 (fr)	2007-05-31
EP1951240A2 (fr)	2008-08-06
AU2006316607A1 (en)	2007-05-31
NZ568313A (en)	2011-11-25
US20070116730A1 (en)	2007-05-24

Publication	Publication Date	Title
ZA200804305B (en)	2009-04-29	Pharmaceutical compositions comprising buprenorphine
IL223545A0 (en)	2013-02-03	Pharmaceutical compositions
IL179809A0 (en)	2007-05-15	Pharmaceutical compositions
GB0408308D0 (en)	2004-05-19	Pharmaceutical compositions
GB0513692D0 (en)	2005-08-10	Novel pharmaceutical compositions
IL188352A0 (en)	2008-04-13	Pharmaceutical compositions
IL186336A0 (en)	2008-01-20	Pharmaceutical composition
ZA200804103B (en)	2009-10-28	Pharmaceutical compositions
IL192091A0 (en)	2008-12-29	Pharmaceutical compositions
PL1837019T3 (pl)	2013-02-28	Kompozycja farmaceutyczna rozpadająca się w ustach
EP1805154A4 (fr)	2009-11-25	Compositions pharmaceutiques
GB0522045D0 (en)	2005-12-07	Pharmaceutical compositions
EP1845944A4 (fr)	2011-07-27	Compositions pharmaceutiques
GB0407351D0 (en)	2004-05-05	Pharmaceutical compositions
GB0400971D0 (en)	2004-02-18	Pharmaceutical compositions
GB0514259D0 (en)	2005-08-17	Pharmaceutical compositions
ZA200803566B (en)	2009-10-28	Pharmaceutical compositions
GB0411502D0 (en)	2004-06-23	Pharmaceutical compositions
GB0502792D0 (en)	2005-03-16	Pharmaceutical compositions
HK1123190A (en)	2009-06-12	Pharmaceutical compositions comprising buprenorphine
GB0525269D0 (en)	2006-01-18	Pharmaceutical compositions
GB0515306D0 (en)	2005-08-31	Pharmaceutical compositions
GB0412733D0 (en)	2004-07-07	Pharmaceutical compositions
GB0420173D0 (en)	2004-10-13	Pharmaceutical compositions
GB0408301D0 (en)	2004-05-19	Pharmaceutical compositions